background
report
sever
case
recov
test
posit
discharg
redetect
posit
rp
howev
clinic
characterist
signific
potenti
caus
rp
patient
remain
elus
method
total
patient
discharg
januari
februari
enrol
analysi
clinic
paramet
rp
nonrp
nrp
patient
group
accord
diseas
sever
hospit
period
clinic
character
readmiss
hospit
analyz
rna
plasma
antibodi
level
detect
use
highsensit
detect
method
find
march
patient
follow
least
day
rp
patient
present
rp
patient
character
less
old
mild
moder
condit
compar
nrp
patient
sever
patient
becam
rp
retrospect
rp
patient
display
fewer
symptom
sustain
remiss
ct
imag
earlier
rna
negativeconvers
similar
plasma
antibodi
level
hospit
period
compar
nrp
patient
readmit
hospit
rp
patient
show
obviou
clinic
symptom
diseas
progress
indic
normal
improv
ct
imag
inflammatori
cytokin
level
close
contact
rp
patient
test
neg
rna
suspici
clinic
symptom
report
howev
rnaneg
sampl
detect
commerci
kit
test
posit
viru
rna
use
hypersensit
method
suggest
carrier
statu
viru
possibl
exist
patient
recov
interpret
result
show
young
mild
patient
seem
rp
patient
discharg
show
obvious
clinic
symptom
diseas
progress
upon
readmiss
sensit
rna
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
sinc
earli
decemb
march
case
coronaviru
diseas
caus
novel
coronaviru
infect
death
report
world
world
health
organ
declar
pandem
gener
less
sever
less
fatal
sar
howev
patient
especi
elderli
comorbid
prone
develop
sever
symptom
requir
emerg
medic
intervent
mani
literatur
retrospect
analyz
clinic
characterist
patient
infect
recent
increas
number
patient
discharg
hospit
receiv
regular
followup
observ
redetect
posit
rp
rna
test
recov
patient
report
manag
rp
patient
attract
wide
attent
howev
number
rp
patient
report
literatur
small
durat
followup
short
addit
clinic
characterist
lack
potenti
impact
signific
rp
patient
remain
unknown
make
difficult
provid
empir
inform
evid
support
manag
patient
recoveri
period
studi
retrospect
analyz
clinic
characterist
rp
patient
nonrp
nrp
patient
recov
found
rp
patient
character
younger
age
milder
condit
also
minor
symptom
sustain
remiss
ct
imag
earlier
rna
negativeconvers
similar
plasma
antibodi
level
hospit
period
show
obviou
diseas
progress
infect
readmit
hospit
hypersensit
detect
method
identifi
rna
molecul
sampl
test
rnaneg
commerci
kit
suggest
carrier
statu
viru
possibl
exist
recov
patient
find
provid
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
key
inform
effect
manag
patient
convalesc
phase
total
confirm
patient
discharg
shenzhen
third
peopl
hospit
januari
februari
enrol
studi
discharg
patient
continu
isol
observ
day
weekli
followedup
rna
detect
perform
time
discharg
patient
followedup
least
two
addit
week
isol
among
rp
patient
readmit
hospit
medic
observ
close
contact
also
followedup
rest
recov
nrp
patient
close
followedup
outsid
hospit
studi
approv
ethic
committe
third
peopl
hospit
shenzhen
waiv
requir
written
patient
consent
retrospect
analysi
patient
gave
oral
consent
particip
retrospect
studi
accord
guidelin
diagnosi
treatment
novel
coronaviru
pneumonia
sixth
edit
publish
nation
health
commiss
peopl
republ
china
first
diagnosi
case
confirm
accord
posit
respiratori
rtpcr
test
discharg
criteria
recov
patient
includ
temperatur
return
normal
day
respiratori
symptom
significantli
improv
signific
absorpt
pulmonari
lesion
chest
ct
imag
least
consecut
neg
rna
test
result
apart
least
hour
rp
patient
confirm
digest
anal
swab
respiratori
posit
rtpcr
test
sinc
februari
evalu
neg
anal
swab
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
supplement
discharg
criteria
shenzhen
third
peopl
hospit
medic
record
recov
covid
patient
includ
rp
patient
review
epidemiolog
demograph
clinic
laboratori
data
patient
collect
summar
analyz
accord
first
chest
ct
imag
post
admiss
extent
pulmonari
inflamm
divid
mild
moder
sever
condit
base
lesion
involv
unilater
lobe
multipl
lobe
lung
lobe
lung
respect
accord
chest
ct
within
day
admiss
remiss
lesion
evalu
temporari
progress
indic
increas
lesion
persist
remiss
indic
stabl
absorb
decreas
lesion
quantit
revers
transcript
polymeras
chain
reaction
qrtpcr
assess
describ
previous
nasopharyng
anal
specimen
collect
hospit
sent
laboratori
viral
transport
case
total
nucleic
acid
extract
extract
sampl
use
qiaamp
rna
viral
kit
qiagen
heiden
germani
quantit
rtpcr
perform
use
china
food
drug
administr
cfda
approv
commerci
kit
specif
detect
geneodx
co
ltd
shanghai
china
sherlock
kit
gift
feng
zhang
lab
accord
manual
rtpcr
assay
provid
ct
valu
number
cycl
requir
fluoresc
signal
cross
threshold
posit
test
higher
ct
valu
correl
lower
viral
load
specimen
consid
posit
ct
valu
neg
viral
load
undetect
specimen
cyclethreshold
valu
higher
repeat
specimen
consid
posit
repeat
result
initi
result
repeat
ct
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
undetect
specimen
consid
neg
procedur
involv
clinic
specimen
perform
biosafeti
level
laboratori
meanwhil
nextgener
sequenc
sampl
three
patient
antibodi
solut
sangon
biotech
ad
plate
respect
incub
minut
five
wash
tetramethylbenzidin
tmb
substrat
sangon
biotech
ad
room
temperatur
dark
minut
reaction
stop
solut
absorb
measur
nm
sampl
run
triplic
elisa
titer
determin
endpoint
dilut
statist
analysi
perform
use
spss
ibm
chicago
statist
test
twosid
signific
differ
consid
p
continu
variabl
evalu
use
median
interquartil
rang
iqr
valu
chisquar
fisher
exact
test
util
compar
proport
categor
variabl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
total
patient
discharg
januari
februari
followedup
least
day
among
mild
moder
sever
patient
account
n
n
n
respect
march
convalesc
patient
n
redetect
rna
posit
followedup
period
none
sever
patient
retest
rna
posit
supplement
tabl
reveal
vast
major
rp
patient
n
younger
year
age
among
patient
younger
year
old
common
compar
age
year
vs
p
tabl
addit
found
rp
patient
character
mild
symptom
percentag
significantli
higher
seen
among
nrp
patient
p
supplement
tabl
signific
differ
gender
distribut
notabl
less
mild
rp
patient
fever
initi
symptom
compar
mild
nrp
patient
p
also
mild
rp
patient
display
upper
respiratori
symptom
first
admiss
mild
nrp
patient
usual
lower
respiratori
symptom
first
admiss
tabl
differ
extent
lesion
first
chest
ct
imag
rp
nrp
patient
moder
stage
howev
incid
rp
found
particularli
close
relat
sustain
remiss
chest
ct
imag
compar
nrp
patient
display
transient
progress
first
hospit
period
tabl
figur
signific
differ
usag
steroid
antivir
therapi
rp
nrp
patient
first
hospit
period
addit
rp
patient
show
higher
incid
histori
travel
live
hubei
provinc
compar
nrp
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
differ
day
last
rna
negativeconvers
sinc
onset
ill
hospit
day
found
rp
nrp
patient
importantli
rna
negativeconvers
occur
mostli
within
week
sinc
onset
ill
among
mild
rp
patient
within
week
sinc
onset
ill
among
moder
rp
patient
contrast
nrp
patient
display
rna
negativeconvers
week
sinc
onset
ill
regardless
mild
moder
statu
tabl
data
show
rp
patient
character
earli
rnaneg
convers
nrp
patient
clear
viru
rel
late
order
evalu
effect
serumspecif
antibodi
level
occurr
rp
analyz
differ
igg
igm
antibodi
level
rp
nrp
patient
discharg
half
rp
nrp
patient
display
medium
level
igg
igm
independ
diseas
sever
howev
differ
antibodi
level
group
patient
supplement
tabl
also
evalu
dynam
igg
igm
level
discharg
readmiss
rp
patient
igg
igm
level
maintain
stabl
level
rp
patient
day
period
data
shown
order
evalu
effect
increas
sampl
site
test
discharg
rp
event
compar
occurr
event
rp
feb
feb
time
neg
anal
swab
detect
ad
discharg
criterion
patient
result
show
statist
differ
occurr
rp
patient
feb
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
feb
vs
p
figur
data
indic
supplement
detect
site
rna
fail
reduc
rp
occurr
convalesc
patient
rp
patient
readmit
hospit
medic
observ
analysi
show
patient
fever
small
number
patient
report
mild
cough
chest
tight
wors
tabl
addit
convalesc
patient
cohort
requir
isol
home
intens
isol
close
contact
produc
march
close
contact
test
neg
rna
suspici
clinic
symptom
report
close
contact
investig
possibl
fals
neg
due
lowsensit
commerci
rna
detect
kit
use
highersensit
method
detect
variou
type
sampl
rp
patient
nrp
patient
similar
ill
day
sampl
rp
patient
sampl
day
sinc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
onset
readmiss
spike
gene
orf
gene
could
detect
posit
use
hypersensit
method
n
gene
rf
gene
detect
posit
use
commerci
detect
kit
eight
fifteen
rp
patient
confirm
rna
posit
use
hypersensit
kit
although
person
confirm
use
commerci
kit
contrast
sampl
nrp
patient
detect
neg
method
data
show
hypersensit
method
potenti
improv
rna
posit
detect
sampl
rp
patient
neg
result
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
sever
studi
shown
exist
rp
patient
howev
clinic
character
well
defin
studi
retrospect
analyz
clinic
followedup
data
cohort
rp
nrp
patient
discharg
period
march
rp
patient
present
account
discharg
patient
followedup
period
rp
patient
display
sever
signific
featur
includ
younger
age
mild
andor
moder
symptom
hospit
consist
previou
report
mild
rp
patient
usual
younger
year
old
moder
rp
patient
younger
year
old
contrast
sever
patient
found
rp
patient
within
similar
followup
period
addit
rp
patient
display
minor
symptom
hospit
less
comorbid
fever
upper
respiratori
symptom
rp
patient
also
maintain
remiss
ct
imag
nrp
patient
data
indic
rp
patient
character
younger
minor
symptom
hospit
period
viru
load
usual
thought
relat
diseas
outcom
present
studi
indic
rna
negativeconvers
occur
commonli
week
sinc
onset
ill
moder
rp
patient
compar
week
moder
nrp
patient
significantli
shorten
rna
negativeconvers
time
may
affect
persist
high
level
adapt
immun
recent
studi
indic
higher
titer
antibodi
plasma
independ
associ
diseas
sever
patient
howev
rp
nrp
patient
display
similar
level
igg
igm
plasma
futur
studi
investig
host
immun
respons
usual
consid
determin
clinic
outcom
especi
viru
infect
also
comprehens
character
clinic
symptom
rp
patient
readmit
hospit
obviou
clinic
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
evid
diseas
progress
recurr
found
rp
patient
includ
ct
imag
laboratori
test
antibiot
steroid
antivir
agent
continu
supplement
oxygen
requir
rp
patient
inflammatori
respons
significantli
reduc
data
indic
diseas
rp
patient
progress
sever
statu
even
rna
detect
posit
import
rp
patient
caus
new
infect
discharg
recent
longitudin
studi
infect
rhesu
macaqu
reinfect
could
occur
convalesc
monkey
longterm
followup
close
contact
rp
patient
warrant
evalu
possibl
risk
rp
underli
mechan
underli
rp
occurr
remain
unclear
possibl
reason
argu
larg
number
expert
relat
sever
virolog
immunolog
sampl
methodolog
factor
virolog
fals
neg
viral
residu
intermitt
viral
releas
viral
distribut
usual
consid
major
factor
data
support
notion
fals
neg
use
commerci
kit
may
partial
account
rp
kit
posit
rate
detect
variou
sampl
rp
patient
rna
detect
neg
n
gene
gene
sever
day
readmiss
hospit
use
commerci
kit
whose
lower
limit
detect
lod
rel
high
copiesml
howev
use
sensit
sherlock
kit
lod
copiesml
sampl
detect
posit
gene
orf
gene
thu
lead
half
posit
subject
present
within
rp
patient
undetect
rna
use
commerci
kit
hospit
contrast
among
sampl
nrp
patient
none
detect
posit
use
either
sherlock
commerci
kit
howev
sampl
confirm
sequenc
sherlock
test
posit
data
shown
therefor
futur
studi
improv
sensit
specif
detect
kit
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
would
accur
identifi
clinic
sampl
anyway
data
indic
fals
posit
detect
current
kit
may
extent
account
occurr
rp
patient
anoth
virolog
factor
longterm
viru
residu
gut
tissu
similar
sar
recent
studi
indic
nucleic
acid
persist
digest
tract
fece
nearli
day
thu
extend
detect
time
necessari
patient
discharg
howev
result
show
ad
anal
swab
deriv
rna
test
neg
discharg
criterion
significantli
reduc
occurr
rp
patient
thu
factor
may
associ
rp
patient
could
exclud
sampl
methodolog
factor
includ
differenti
sampl
oper
method
sampl
qualiti
technician
expertis
level
could
exclud
immunolog
factor
includ
low
mucos
immun
respons
low
iga
level
factor
may
take
uncertain
risk
lead
occurr
rp
patient
futur
studi
reduc
rp
occurr
use
hypersensit
detect
kit
hyperspecif
combin
detect
multipl
sampl
immun
marker
studi
sever
limit
first
studi
singlecent
retrospect
studi
durat
followup
short
clinic
observ
need
evalu
potenti
risk
recurr
infect
second
dynam
rna
patient
need
monitor
evalu
rp
patient
second
addit
studi
measur
dynam
chang
serum
specif
antibodi
level
rp
patient
evalu
continu
protect
effect
serum
specif
antibodi
patient
final
differenti
rp
patient
relaps
one
convalesc
subject
two
distinct
prevent
control
strategi
adopt
taken
togeth
find
reveal
clinic
featur
rp
patient
show
recurr
clinic
symptom
abnorm
laboratori
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
test
howev
hypersensit
detect
method
reveal
exist
rna
rp
patient
specimen
test
neg
use
commerci
kit
therefor
necessari
develop
accur
quantit
assess
rna
dynam
addit
discharg
criteria
help
physician
make
decis
studi
provid
valuabl
empir
inform
clinic
evid
support
effect
manag
patient
convalesc
period
studi
evalu
potenti
clinic
signific
transmiss
risk
rp
patient
declar
compet
interest
posit
rna
test
recov
patient
report
whose
manag
attract
wide
attent
howev
number
recov
patient
posit
rna
test
report
literatur
small
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
durat
followup
short
clinic
characterist
lack
potenti
impact
signific
patient
remain
unknown
lack
data
make
difficult
provid
empir
inform
evid
support
manag
patient
recoveri
period
first
young
mild
patient
prone
test
posit
discharg
patient
display
fewer
symptom
sustain
remiss
ct
imag
earlier
rna
negativeconvers
similar
plasma
antibodi
level
hospit
period
compar
nrp
patient
second
upon
readmiss
patient
show
obvious
clinic
symptom
diseas
progress
howev
hypersensit
detect
method
potenti
recogn
fals
neg
commerci
kit
current
evid
strongli
support
effect
manag
patient
convalesc
phase
case
recov
test
posit
discharg
redetect
posit
rp
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
number
contact
symptom
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
redetect
posit
patient
nonredetect
posit
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
rp
redetect
posit
patient
nrp
nonredetect
posit
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
note
rp
redetect
posit
patient
nrp
nonredetect
posit
patient
high
titer
medium
titer
low
titer
less
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
